El pódcast como herramienta docente y divulgativa: conversaciones entre estudiantes y expertos en microbiología

En el marco de este proyecto Innova-Docencia se puso en marcha el pódcast "Esto va de Micro" que se encuentra disponible en la plataforma iVoox. En los programas grabados, estudiantes de la Universidad Complutense realizaron entrevistas a expertos con los que charlaban sobre temas de actualidad en el campo de la Microbiología. El pódcast ha sido todo un reto para profesores y estudiantes pero ha conseguido de manera exitosa llevar la Microbiología a un público general fuera de la Universidad

Una ventana abierta : diseño de la pagina web didáctica de la comunidad educativa del CPEE Parayas

El trabajo está publicado en Internet. En el CD anexo se encuentra la web realizada. Resumen basado en ficha elaborada por los autoresEl trabajo se ha realizado en el aula de informática del CPEE Parayas por 24 maestros de educación especial pertenecientes al centro. Los objetivos son el desarrollo de la web del centro, la apertura al conocimiento de la comunidad educativa cántabra, el conocimiento de las herramientas de edición web y el intercambio de experiencias educativas con otros centros. Para esto se ha desarrollado la web, definiendo primero su estructura básica, dando a los profesores lecciones de html y repartiendo el trabajo en los distintos ciclos. La valoración del equipo de trabajo sobre la actividad, es muy positiva, tanto para los alumnos, como para ellos mismos. Se han empleado diversos materiales de tipo informático (software, cámara digital, etc.).Consejería de Educación y Juventud de CantabriaCantabriaES

Down syndrome as risk factor for respiratory syncytial virus hospitalization : A prospective multicenter epidemiological study

Respiratory syncytial virus (RSV) infection in childhood, particularly in premature infants, is associated with significant morbidity and mortality. To compare the hospitalization rates due to RSV infection and severity of disease between infants with and without Down syndrome (DS) born at term and without other associated risk factors for severe RSV infection. In a prospective multicentre epidemiological study, 93 infants were included in the DS cohort and 68 matched by sex and data of birth (±1 week) and were followed up to 1 year of age and during a complete RSV season. The hospitalization rate for all acute respiratory infection was significantly higher in the DS cohort than in the non-DS cohort (44.1% vs 7.7%, P<.0001). Hospitalizations due to RSV were significantly more frequent in the DH cohort than in the non-DS cohort (9.7% vs 1.5%, P=.03). RSV prophylaxis was recorded in 33 (35.5%) infants with DS. The rate of hospitalization according to presence or absence of RSV immunoprophylaxis was 3.0% vs 15%, respectively. Infants with DS showed a higher rate of hospitalization due to acute lower respiratory tract infection and RSV infection compared to non-DS infants. Including DS infants in recommendations for immunoprophylaxis of RSV disease should be considered

Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective